Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1546 AL 1560

Fluid Biomarkers for Trial Enrichment and Effect Monitoring in Disease-Modifying Treatments for Parkinson Disease

Parnetti L, Paoletti FP.

Neurology. 2024 Mar 12;102(5):e209194. doi: 10.1212/WNL.0000000000209194. Epub 2024 Feb 5.

Neurotransmitters and Networks Interplay in Cognition and Gait Disturbances in Patients With Parkinson Disease: Beyond Lesion Localization

Merino Ruiz MC, Mortari MR.

Neurology. 2024 Aug 13;103(3):e209704. doi: 10.1212/WNL.0000000000209704. Epub 2024 Jul 8.

Neuropathologic Processes Linked to Brain Network Resilience in Parkinson Disease: Local or Distributed Effects?

Dayan E.

Neurology. 2024 Aug 27;103(4):e209731. doi: 10.1212/WNL.0000000000209731. Epub 2024 Jul 23.

Spinal Solitary Plasmacytoma With Minimal Marrow Involvement Presenting With Epidural Spinal Cord Compression

Al-Handola R, Banerjee U, Navari Y, Ayad S, Marcus H.

Cureus. 2024 Jan 17;16(1):e52460. doi: 10.7759/cureus.52460. eCollection 2024 Jan.

Effects of right unilateral ultra-brief pulse electroconvulsive therapy in a depressed patient with dementia with Lewy bodies: a longitudinal case report

Yamaguchi Y, Kobayashi R, Muraosa H, Numazawa T, Morioka D, Sakamoto K, Suzuki A.

Psychogeriatrics. 2024 Jul;24(4):1030-1032. doi: 10.1111/psyg.13127. Epub 2024 Apr 16.

Spectrum of delayed post-hypoxic leukoencephalopathy syndrome: A systematic review

Srichawla BS, Garcia-Dominguez MA.

World J Clin Cases. 2024 Oct 16;12(29):6285-6301. doi: 10.12998/wjcc.v12.i29.6285.

Incidental Finding of Double Posterior Belly of Digastric Muscle in Head and Neck Cancer Patient

Sagalow ES, Wang R, Babu J, Bigcas JL, Okuyemi O.

Ann Otol Rhinol Laryngol. 2024 Dec;133(12):1033-1036. doi: 10.1177/00034894241284187. Epub 2024 Sep 24.

Surgicogenomics in GBA1-related Parkinson disease: Is the glass half full or half empty?

Salles PA, Fernández HH, Mata IF.

Parkinsonism Relat Disord. 2024 Jul;124:106981. doi: 10.1016/j.parkreldis.2024.106981. Epub 2024 Apr 24.

Imaging Studies Play a Pivotal Role in Elucidating the Pathophysiology of Parkinson Disease

Yamada K.

Radiology. 2024 Jun;311(3):e241285. doi: 10.1148/radiol.241285.

A Comprehensive Review of the Docking Studies of Chalcone for the Development of Selective MAO-B Inhibitors

Krishna A, Kumar S, Sudevan ST, Singh AK, Pappachen LK, Rangarajan TM, Abdelgawad MA, Mathew B.

CNS Neurol Disord Drug Targets. 2024;23(6):697-714. doi: 10.2174/1871527322666230515155000.

A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists

Soni S, Lukhey MS, Thawkar BS, Chintamaneni M, Kaur G, Joshi H, Ramniwas S, Tuli HS.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4643-4656. doi: 10.1007/s00210-024-02994-z. Epub 2024 Feb 13.

Modeling the volume of tissue activated in deep brain stimulation and its clinical influence: a review

Patrick EE, Fleeting CR, Patel DR, Casauay JT, Patel A, Shepherd H, Wong JK.

Front Hum Neurosci. 2024 Apr 10;18:1333183. doi: 10.3389/fnhum.2024.1333183. eCollection 2024.

A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets

Aziz N, Wal P, Patel A, Prajapati H.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7307-7336. doi: 10.1007/s00210-024-03109-4. Epub 2024 May 11.

E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases

Lu L, Jifu C, Xia J, Wang J.

Biomed Pharmacother. 2024 Jun;175:116753. doi: 10.1016/j.biopha.2024.116753. Epub 2024 May 17.

Blood-based therapies to combat neurodegenerative diseases

Lee JY, Lim MCX, Koh RY, Tsen MT, Chye SM.

Metab Brain Dis. 2024 Jun;39(5):985-1004. doi: 10.1007/s11011-024-01368-x. Epub 2024 Jun 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias